# FDA Inspection 598116 - Bioreliance Ltd. - July 02, 2009

Source: https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/a9debd83-d80c-4241-8596-2aa0251bbc8c
Source feed: FDA_Inspections

> FDA Inspection 598116 for Bioreliance Ltd. on July 02, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 598116
- Company Name: Bioreliance Ltd.
- Inspection Date: 2009-07-02
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1288500 - 2025-12-05](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/e0050eb3-232d-48bc-a614-c2fa80560997)
- [FDA Inspection 1225550 - 2023-11-07](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/08c8c427-f655-4374-8d95-7655ea32caf0)
- [FDA Inspection 1202961 - 2021-03-17](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/cf0d67b7-2068-4bed-8b69-aa2c67ca1871)
- [FDA Inspection 1108960 - 2019-09-27](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/c26c2b64-49cf-4023-81ce-8b8422935fd5)
- [FDA Inspection 1093195 - 2019-03-15](https://www.keypedia.com/records/fda_inspections/bioreliance-ltd/6d908b43-3b15-436a-839a-aaef7318e1d3)

Company: https://www.keypedia.com/companies/bioreliance-ltd/fec1a160-db6a-4ebc-9632-aa6e2996e17e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c